Gastrointestinal Tumors
Conditions
Interventions
Observation group:NONE
Sponsors
Henan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 18 years or above, with a clear pathological diagnosis of primary hepatocellular carcinoma, gastric cancer, esophageal cancer, colorectal cancer, etc. (2) Have received at least one cycle of ICIs monotherapy or dual therapy or combination chemotherapy. (3) Are aware of the diagnosis and condition. (4) Have clear consciousness and can understand the content of this study, and can communicate and answer questions effectively through written, electronic devices or interviews. (5) Have given informed consent and are voluntarily participating in this study.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Suffering from other serious diseases simultaneously: For instance, having uncontrolled severe infections, severe cardiovascular or cerebrovascular diseases (such as unstable angina pectoris, myocardial infarction within the past 6 months), uncontrolled epilepsy or central nervous system disorders, etc. The researchers will determine that the participant is not suitable for participation. (2) Having mental or cognitive impairments: For example, having a history of mental illness, cognitive dysfunction or any other condition that prevents understanding the study requirements or accurately reporting one's own feelings. (3) Having other conditions that affect the assessment, such as active autoimmune diseases, interstitial lung disease, conditions requiring immunosuppressive therapy, pregnancy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom cognition and incidence of adverse reactions;self-management;quality of life;health literacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological symptoms;oral frailty; | — |
Countries
China
Contacts
Public ContactTao Li
Henan Cancer Hospital
Outcome results
None listed